Financials
- Market Capitalization 209.74 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.08
ratio cours/chiffre d'affaires
0.69
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3562 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 2.15 USD | +8.59% | +4.88% | +66.67% | +90.27% | 215.55 M USD | ||
| 3566 | DERM Journey Medical Corporation - Common Stock | 7.57 USD | +2.16% | +0.93% | +18.84% | +7.38% | 213.66 M USD | ||
| 3688 | LFCR Lifecore Biomedical, Inc. - Common Stock | 4.39 USD | -1.57% | -5.39% | -2.44% | -40.76% | 166.17 M USD | ||
| 3717 | OGI Organigram Global Inc. - Common Shares | 1.18 USD | -2.48% | -6.35% | +26.88% | -17.19% | 158.66 M USD |